Trial
NCT04325802
Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Minnesota
Collaborators
—
Condition
Atopic Dermatitis
Intervention
Naltrexone
Why stopped
Covid-19 pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-04